Glenmark Pharmaceuticals consolidated net profit declines 86.23% in the June 2025 quarter
(15 Aug 2025)

Back
Net profit of Glenmark Pharmaceuticals declined 86.23% to Rs 46.87 crore in the quarter ended June 2025 as against Rs 340.27 crore during the previous quarter ended June 2024. Sales declined 5.09% to Rs 3059.33 crore in the quarter ended June 2025 as against Rs 3223.30 crore during the previous quarter ended June 2024.

ParticularsQuarter Ended
Jun. 2025Jun. 2024% Var.
Sales3059.333223.30 -5
OPM %18.9818.25 -
PBDT548.73580.12 -5
PBT418.81462.33 -9
NP46.87340.27 -86

Copyright © 2024 Arihant Capital Markets Ltd. All rights Reserved.

Designed,Developed and Content powered by CMOTS Infotech (ISO 9001:2015 certified)

x
  • QR-CodeNew